Establishment Labs price to book ratio ESTA

Market value divided by the book value of the company's net assets, since 2018.

Today, Oct 23, 2026: 88.0×
8-year median: 24.9×
Against its 8-year history: 88th; percentile: 0 is its lowest day, 100 its highest
8-year range: 4.0× to 198×
Peer median: 4.8×

Establishment Labs' price to book ratio is 88.0× as of Oct 23, 2026.

That is above its 8-year median of 24.9×, higher than on 88% of days in the last 8 years.

Over that time it ranged from 4.0× in Jul 2020 to 198× in Oct 2018.

The median for 10 medical instruments and supplies stocks of a similar size is 4.8×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	88.0×	68.9×	184×
2025	136×	16.3×	136×
2024	39.3×	18.2×	80.1×
2023	21.9×	14.8×	27.9×
2022	82.7×	19.4×	102×
2021	26.4×	11.1×	28.1×
2020	11.0×	4.0×	13.5×
2019	12.7×	6.5×	12.7×
2018	6.9×	5.9×	198×

Against its peers

Companies in Medical - Instruments & Supplies nearest Establishment Labs' size, closest first, today.

Company	Price to book ratio
ESTAEstablishment Labs	88.0×
LMATLemaitre Vascular	4.6×
INSPInspire Medical Systems	2.5×
UFPTUFP Technologies	5.0×
EYENational Vision	1.6×
CDRECadre	3.7×
BVSBioventus	5.5×
ATRCAtriCure	5.8×
STAAStaar Surgical	3.1×
WRBYWarby Parker	8.2×
IRMDIradimed	10.8×
Peer median	4.8×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Establishment Labs

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.